Clinical Trial Update: Vildagliptin Glycemic Profiles Assessment Using a Continuous Glucose Monitoring Device. [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial update from Novartis assessing glycemic profiles of vildagliptin in Type 2 diabetes mellitus using continuous glucose monitorin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type II Diabetes Mellitus | Phase 3 | Status: COMPLETED